MB, Levis & Associates’s Organon & Co OGN Stock Holding History

MB, Levis & Associates’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72K	Hold	201	–	–	﹤0.01%	221
2026 Q1	$1.2K	Buy	201 +1	+0.5%	+$8	﹤0.01%	220
2025 Q4	$1.43K	Hold	200	–	–	﹤0.01%	229
2025 Q3	$2.14K	Hold	200	–	–	﹤0.01%	219
2025 Q2	$1.94K	Hold	200	–	–	﹤0.01%	244
2025 Q1	$2.98K	Hold	200	–	–	﹤0.01%	240
2024 Q4	$2.98K	Hold	200	–	–	﹤0.01%	249
2024 Q3	$3.83K	Hold	200	–	–	﹤0.01%	235
2024 Q2	$4.14K	Hold	200	–	–	﹤0.01%	227
2024 Q1	$3.76K	Hold	200	–	–	﹤0.01%	231
2023 Q4	$2.88K	Buy	200 +100	+100%	+$1.36K	﹤0.01%	237
2023 Q3	$1.74K	Hold	100	–	–	﹤0.01%	249
2023 Q2	$2.08K	Hold	100	–	–	﹤0.01%	248
2023 Q1	$2.35K	Hold	100	–	–	﹤0.01%	243
2022 Q4	$2.79K	Buy	+100	New	+$2.56K	﹤0.01%	225

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

MB, Levis & Associates's OGN Position: Q2 2026 in Review

MB, Levis & Associates held its Organon & Co (OGN) position steady in Q2 2026 at 201 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

MB, Levis & Associates first reported a position in OGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.14K in Q2 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

MB, Levis & Associates held 201 shares of Organon & Co worth $2.72K as of Q2 2026.
MB, Levis & Associates left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #221 holding.
MB, Levis & Associates first reported a position in Organon & Co in Q4 2022 and has held it in 15 quarters since.
MB, Levis & Associates's Organon & Co position peaked at $4.14K in Q2 2024.
635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.